Ventas, Inc. (NYSE:VTR) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. lowered its stake in shares of Ventas, Inc. (NYSE:VTR) by 6.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,035,492 shares of the real estate investment trust’s stock after selling 1,299,802 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.05% of Ventas worth $1,015,354,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently modified their holdings of VTR. Global Retirement Partners LLC increased its position in shares of Ventas by 3.0% in the 1st quarter. Global Retirement Partners LLC now owns 6,535 shares of the real estate investment trust’s stock worth $349,000 after purchasing an additional 193 shares during the last quarter. Assetmark Inc. raised its position in shares of Ventas by 10.0% during the 4th quarter. Assetmark Inc. now owns 2,362 shares of the real estate investment trust’s stock valued at $116,000 after acquiring an additional 214 shares in the last quarter. Berman Capital Advisors LLC boosted its holdings in Ventas by 38.6% in the first quarter. Berman Capital Advisors LLC now owns 884 shares of the real estate investment trust’s stock worth $47,000 after purchasing an additional 246 shares during the period. BBVA USA Bancshares Inc. raised its holdings in shares of Ventas by 5.6% during the first quarter. BBVA USA Bancshares Inc. now owns 4,872 shares of the real estate investment trust’s stock worth $260,000 after purchasing an additional 259 shares during the period. Finally, Advisors Management Group Inc. ADV boosted its holdings in shares of Ventas by 0.3% in the 1st quarter. Advisors Management Group Inc. ADV now owns 86,171 shares of the real estate investment trust’s stock valued at $4,596,000 after buying an additional 270 shares during the period. Institutional investors and hedge funds own 91.08% of the company’s stock.

Shares of Ventas stock traded down $0.06 on Friday, reaching $57.63. 24,131 shares of the company were exchanged, compared to its average volume of 2,096,711. Ventas, Inc. has a fifty-two week low of $32.19 and a fifty-two week high of $58.43. The stock has a market cap of $21.62 billion, a price-to-earnings ratio of -230.76, a price-to-earnings-growth ratio of 6.43 and a beta of 1.27. The company has a debt-to-equity ratio of 1.17, a current ratio of 0.69 and a quick ratio of 0.69. The business has a fifty day simple moving average of $55.22.

Ventas (NYSE:VTR) last posted its quarterly earnings data on Friday, May 7th. The real estate investment trust reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.70 by ($0.85). Ventas had a negative return on equity of 0.89% and a negative net margin of 2.47%. The company had revenue of $910.29 million for the quarter, compared to analyst estimates of $896.37 million. During the same quarter in the previous year, the firm posted $0.97 EPS. Ventas’s quarterly revenue was down 10.1% on a year-over-year basis. As a group, research analysts anticipate that Ventas, Inc. will post 2.88 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 14th. Investors of record on Thursday, July 1st will be given a $0.45 dividend. The ex-dividend date of this dividend is Wednesday, June 30th. This represents a $1.80 annualized dividend and a dividend yield of 3.12%. Ventas’s dividend payout ratio (DPR) is presently 54.22%.

VTR has been the subject of a number of analyst reports. Morgan Stanley boosted their price objective on Ventas from $52.00 to $58.00 and gave the company an “equal weight” rating in a research report on Monday, March 15th. Royal Bank of Canada increased their price objective on Ventas from $58.00 to $62.00 and gave the stock an “outperform” rating in a report on Monday, May 24th. Zacks Investment Research upgraded Ventas from a “strong sell” rating to a “hold” rating and set a $58.00 price target for the company in a research report on Thursday, April 8th. Wells Fargo & Company raised their price target on Ventas from $40.00 to $50.00 in a report on Thursday, March 11th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Ventas from $50.00 to $61.00 and gave the company a “hold” rating in a research report on Thursday, June 3rd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $52.83.

In other Ventas news, CEO Debra A. Cafaro sold 18,076 shares of the firm’s stock in a transaction dated Monday, May 3rd. The stock was sold at an average price of $55.65, for a total transaction of $1,005,929.40. Following the completion of the sale, the chief executive officer now directly owns 759,352 shares in the company, valued at approximately $42,257,938.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard I. Gilchrist sold 8,934 shares of Ventas stock in a transaction dated Wednesday, March 24th. The shares were sold at an average price of $54.04, for a total value of $482,793.36. Following the transaction, the director now directly owns 41,210 shares in the company, valued at approximately $2,226,988.40. The disclosure for this sale can be found here. Insiders sold a total of 45,086 shares of company stock valued at $2,452,716 in the last ninety days. Company insiders own 1.30% of the company’s stock.

Ventas Profile

Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries Â- healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population.

Featured Article: Are we seeing the beginning of a new bubble?

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.